Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study

Background A lack of longitudinal studies has made it difficult to establish the direction of associations between circulating concentrations of low-grade chronic inflammatory markers, such as C-reactive protein and interleukin-6, and cognitive symptoms of depression. The present study sought to assess whether C-reactive protein and interleukin-6 predict cognitive symptoms of depression or whether these symptoms predict inflammatory markers. Method In a prospective occupational cohort study of British white-collar civil servants (the Whitehall II study), serum C-reactive protein, interleukin-6 and cognitive symptoms of depression were measured at baseline in 1991–1993 and at follow-up in 2002–2004, an average follow-up of 11.8 years. Symptoms of depression were measured with four items describing cognitive symptoms of depression from the General Health Questionnaire. The number of participants varied between 3339 and 3070 (mean age 50 years, 30% women) depending on the analysis. Results Baseline C-reactive protein (β=0.046, p=0.004) and interleukin-6 (β=0.046, p=0.005) predicted cognitive symptoms of depression at follow-up, while baseline symptoms of depression did not predict inflammatory markers at follow-up. After full adjustment for sociodemographic, behavioural and biological risk factors, health conditions, medication use and baseline cognitive systems of depression, baseline C-reactive protein (β=0.038, p=0.036) and interleukin-6 (β=0.041, p=0.018) remained predictive of cognitive symptoms of depression at follow-up. Conclusions These findings suggest that inflammation precedes depression at least with regard to the cognitive symptoms of depression.

[1]  D. Goldberg.  The detection of psychiatric illness by questionnaire : a technique for the identification and assessment of non-psychotic psychiatric illness , 1972 .

[2]  R. Lévy.  The detection of psychiatric illness by questionnaire , 1973 .

[3]  D. Goldberg,et al.  A scaled version of the General Health Questionnaire , 1979, Psychological Medicine.

[4]  Great Britain. Foreign Office.,et al.  Labour force survey , 1982 .

[5]  Gower Street,et al.  Health inequalities among British civil servants: the Whitehall II study , 1991, The Lancet.

[6]  M. Marmot,et al.  Social class and minor psychiatric disorder in British Civil Servants: a validated screening survey using the General Health Questionnaire , 1992, Psychological Medicine.

[7]  Some power considerations when deciding to use transformations. , 1994, Statistics in medicine.

[8]  J. R. Kemm,et al.  Alcohol and the Heart in Perspective: Sensible Limits Reaffirmed , 1995, Journal of the Royal College of Physicians of London.

[9]  H. Meltzer,et al.  Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. , 1995, Journal of affective disorders.

[10]  E. Bosmans,et al.  Increased serum interleukin-1-receptor-antagonist concentrations in major depression. , 1995, Journal of affective disorders.

[11]  J. Weatherbee,et al.  Circadian characteristics of circulating interleukin-6 in men. , 1995, The Journal of allergy and clinical immunology.

[12]  M. Marmot,et al.  Childhood social circumstances and psychosocial and behavioural factors as determinants of plasma fibrinogen , 1996, The Lancet.

[13]  H. Cohen,et al.  Association of Interleukin‐6 and Other Biologic Variables with Depression in Older People Living in the Community , 1999, Journal of the American Geriatrics Society.

[14]  C. Y. Li,et al.  A review of the healthy worker effect in occupational epidemiology. , 1999, Occupational medicine.

[15]  M. Marmot,et al.  When does cardiovascular risk start? Past and present socioeconomic circumstances and risk factors in adulthood. , 1999, Journal of epidemiology and community health.

[16]  I. Kushner,et al.  Acute-phase proteins and other systemic responses to inflammation. , 1999, The New England journal of medicine.

[17]  M. Woodward,et al.  Associations of blood rheology and interleukin‐6 with cardiovascular risk factors and prevalent cardiovascular disease , 1999, British journal of haematology.

[18]  K. Williams,et al.  Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.

[19]  M H Wener,et al.  The influence of age, sex, and race on the upper reference limit of serum C-reactive protein concentration. , 2000, The Journal of rheumatology.

[20]  J. Manson,et al.  C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. , 2001, JAMA.

[21]  Ronald Glaser,et al.  Emotions, morbidity, and mortality: new perspectives from psychoneuroimmunology. , 2002, Annual review of psychology.

[22]  M. Wichers,et al.  The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans. , 2002, The international journal of neuropsychopharmacology.

[23]  R. Carney,et al.  Depression as a risk factor for cardiac mortality and morbidity: a review of potential mechanisms. , 2002, Journal of psychosomatic research.

[24]  M Marmot,et al.  Job strain, job demands, decision latitude, and risk of coronary heart disease within the Whitehall II study , 2003, Journal of epidemiology and community health.

[25]  Inflammatory proteins and depression in the elderly. , 2003, Epidemiology.

[26]  M. Woodward,et al.  C‐reactive protein: associations with haematological variables, cardiovascular risk factors and prevalent cardiovascular disease , 2003, British journal of haematology.

[27]  J. Wardle,et al.  Social inequalities in depressive symptoms and physical functioning in the Whitehall II study: exploring a common cause explanation , 2003, Journal of epidemiology and community health.

[28]  L. Ferrucci,et al.  Inflammatory markers and depressed mood in older persons: results from the health, aging and body composition study , 2003, Biological Psychiatry.

[29]  Meena Kumari,et al.  Prospective study of social and other risk factors for incidence of type 2 diabetes in the Whitehall II study. , 2004, Archives of internal medicine.

[30]  B. Dahlöf,et al.  Surrogate markers for cardiovascular disease: structural markers. , 2004, Circulation.

[31]  T. Erlinger,et al.  Depression and C-reactive protein in US adults: data from the Third National Health and Nutrition Examination Survey. , 2004, Archives of internal medicine.

[32]  N. Rifai,et al.  CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice Report From the Laboratory Science Discussion Group , 2004, Circulation.

[33]  Vilmundur Gudnason,et al.  C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. , 2004, The New England journal of medicine.

[34]  Paul M. Ridker,et al.  CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease Application to Clinical and Public Health Practice: Report From the Clinical Practice Discussion Group , 2004 .

[35]  A. Newman,et al.  The metabolic syndrome, inflammation, and risk of cognitive decline. , 2004, JAMA.

[36]  Farzaneh A. Sorond,et al.  Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: systematic review and meta-analysis , 2005, The Lancet Neurology.

[37]  Michael Marmot,et al.  Cohort Profile: the Whitehall II study. , 2005, International journal of epidemiology.

[38]  M. Marmot,et al.  Psychological Distress as a Predictor of CHD Events in Men: The Effect of Persistence and Components of Risk , 2005, Psychosomatic medicine.

[39]  V. Meyer-Rochow,et al.  The Association Between C-Reactive Protein Levels and Depression: Results from the Northern Finland 1966 Birth Cohort Study , 2006, Biological Psychiatry.

[40]  R. Dantzer,et al.  Inflammation, sickness behaviour and depression , 2006 .

[41]  N. Frasure-smith,et al.  Recent Evidence Linking Coronary Heart Disease and Depression , 2006, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[42]  D. Ford,et al.  Minor depression as a predictor of the first onset of major depressive disorder over a 15‐year follow‐up , 2006, Acta psychiatrica Scandinavica.

[43]  J. Viikari,et al.  Depressive symptoms and C-reactive protein: The Cardiovascular Risk in Young Finns Study , 2006, Psychological Medicine.

[44]  C. Nemeroff,et al.  Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress. , 2006, The American journal of psychiatry.

[45]  A. Steptoe.  Depression and Physical Illness: List of contributors , 2006 .

[46]  Andrew H. Miller,et al.  Cytokines sing the blues: inflammation and the pathogenesis of depression. , 2006, Trends in immunology.

[47]  R. Araya,et al.  Detecting common mental disorders in primary care in India: a comparison of five screening questionnaires , 2007, Psychological Medicine.

[48]  T. Kamarck,et al.  Negative emotions and 3-year progression of subclinical atherosclerosis. , 2007, Archives of general psychiatry.

[49]  R. Dantzer,et al.  Named Series: Twenty Years of Brain, Behavior, and Immunity Twenty years of research on cytokine-induced sickness behavior , 2007 .

[50]  K. Matthews,et al.  Depressive symptoms and production of proinflammatory cytokines by peripheral blood mononuclear cells stimulated in vitro , 2007, Brain, Behavior, and Immunity.

[51]  Richie Poulton,et al.  Childhood maltreatment predicts adult inflammation in a life-course study , 2007, Proceedings of the National Academy of Sciences.

[52]  T. Seeman,et al.  Psychosocial factors and inflammation in the multi-ethnic study of atherosclerosis. , 2007, Archives of internal medicine.

[53]  J. Gallacher,et al.  Psychological distress, physical illness and risk of myocardial infarction in the Caerphilly study , 2007, Psychological Medicine.

[54]  A. Beekman,et al.  Inflammatory markers in late-life depression: results from a population-based study. , 2008, Journal of affective disorders.

[55]  I. Deary,et al.  A hierarchy of distress: Mokken scaling of the GHQ-30 , 2008, Psychological Medicine.